Filter
1036
Filtered Results: 1036
Text search:
World
Health
Organization
Eastern
Mediterranean
Featured
Recommendations
131
New Publications
192
Language
Document type
No document type
368
Studies & Reports
281
Guidelines
152
Manuals
72
Strategic & Response Plan
59
Fact sheets
32
Situation Updates
22
Training Material
20
Resource Platforms
16
Infographics
10
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
101
Syria
37
Africa
27
Middle East and North Africa
25
Western and Central Europe
22
Somalia
14
Yemen
13
Sudan
11
Latin America and the Carribbean
9
South–East Asia Region
9
Ethiopia
9
Pakistan
9
Nigeria
8
Afghanistan
8
West and Central Africa
8
Eastern Europe
8
Kenya
7
Congo, Democratic Republic of
7
East and Southern Africa
6
Lebanon
6
South Africa
6
Liberia
6
Sierra Leone
5
Jordan
5
Eastern Europe and Central Asia
5
Uganda
5
Myanmar / Burma
5
Nepal
4
Turkey
4
Rwanda
4
Iran
4
Senegal
4
Asia
4
Saudi Arabia
4
Iraq
4
India
4
Ukraine
3
Ghana
3
China
3
Venezuela
3
Russia
3
Egypt
3
Greece
3
Libya
3
North Macedonia
2
Thailand
2
Benin
2
Albania
2
USA
2
Cambodia
2
Bangladesh
2
Brazil
2
Djibouti
2
South Sudan
2
Ecuador
2
Madagascar
2
Colombia
1
Mexico
1
Serbia
1
Cameroon
1
Niger
1
Burkina Faso
1
Malawi
1
Morocco
1
Qatar
1
Philippines
1
Guinea
1
Italy
1
Croatia
1
Tanzania
1
Western Pacific Region
1
Paraguay
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
151
Clinical Guidelines
142
Public Health
115
Women & Child Health
85
Key Resources
51
Capacity Building
27
Pharmacy & Technologies
20
Toolboxes
Mental Health
133
COVID-19
111
Planetary Health
66
Rapid Response
56
TB
50
HIV
48
NTDs
46
Refugee
43
NCDs
43
Conflict
41
Global Health Education
40
Caregiver
39
AMR
38
Disability
31
Pharmacy
24
Ebola
20
Polio
17
Natural Hazards
14
Cholera
13
Zika
9
Health Financing Toolbox
6
Specific Hazards
4
Social Ethics
1
Typhoon
1
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Lack of trained providers capable of identifying which labouring women could benefit from assisted vaginal birth (AVB), and of safely performing the procedure is a major barrier for its use. Education and training are, therefore, considered crucial for building skills and confidence in conducting AV...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
